PhRMA
MAY 1, 2023
The Pharmaceutical Research and Manufacturers of America (PhRMA) today launched a new ad campaign that continues to shed light on the role of pharmacy benefit managers (PBMs) in driving up health care costs and denying coverage of lifesaving medicines.
Drug Topics
MAY 1, 2023
Though the Omicron variant caused the most symptoms in pediatric patients, there were no differences in adverse outcomes by COVID-19 variant.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
MAY 1, 2023
Too many Americans are struggling to access and afford their health care. While policy debates about how to address these issues can seem never ending, American adults largely agree on what state policymakers should be doing to help deliver relief to patients at the pharmacy counter.
Drug Topics
MAY 1, 2023
Pharmacists can reach the members of their community through creative use of social media platforms such as Instagram and TikTok.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Is Right For Me
MAY 1, 2023
There are a lot of misconceptions and myths about careers in pharmacy and we’re on a mission to change that! Let’s debunk some of the most common myths about pharmacy careers. Pharmacy Myth 1: Pharmacists only work in retail settings. Pharmacists work in a wide variety of practice settings and we highlight a portion of them on our Novel Practice Settings page.
Pharmacy Times
MAY 1, 2023
Analysis shows that the ratio of neutralizing antibody geometric mean titers in adolescents compared with young adults was 1.5 after vaccination with NVX-CoV2373.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MAY 1, 2023
Given the increasing value of patient satisfaction in determining the quality of care in the hospital reimbursement model, research is flourishing with a focus on identifying the factors that could positively influence patient satisfaction outcomes.
STAT
MAY 1, 2023
Over glasses of Chablis at Fleming by Le Bilboquet in Manhattan, two longtime friends and biotech lifers hashed out the deal that will bring their wending and colorful careers back together after three decades. Jeremy Levin, the professorial executive who has become one of the industry’s loudest voices on matters of social justice, is getting back into business with Sam Waksal, a hit-making drug developer with a gift for eloquence and a biography that doubles as biotech’s great unp
Pharmacy Times
MAY 1, 2023
Session at the 2023 Asembia Summit notes that pharmacists play a particularly important role in the large multidisciplinary care team needed for Rett syndrome management.
Pharmaceutical Technology
MAY 1, 2023
Astellas Pharma has entered into a definitive agreement to buy US-based biopharmaceutical company Iveric bio, in a deal valued at nearly $5.9bn. Under the deal terms, the company, through Astellas US Holding’s wholly owned subsidiary Berry Merger Sub, will acquire all the outstanding Iveric Bio shares for $40.00 in cash for each share. Both the companies’ Boards of Directors have unanimously approved the deal.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MAY 1, 2023
Pharmacists play key roles in navigating prior authorizations and other limits on utilization, as well as educating and listening to patients and caregivers.
PharmaVoice
MAY 1, 2023
The CEO of Ventoux Biosciences has the disease that his company is aiming to treat, and it's driving him to find better medications.
Pharmacy Times
MAY 1, 2023
Investigators suggest that a checklist completed by physicians and family members of individuals with severe acute brain injury may improve management needs.
STAT
MAY 1, 2023
This is part of a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution. For nearly a decade, Novartis aggressively pursued a drug candidate for muscle disorders, testing it on people with chronic inflammation, elderly people with frailty, hip surgery patients, and other groups.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
MAY 1, 2023
Molidustat oral suspension is also the first approval for cats under the FDA’s expanded conditional approval pathway.
STAT
MAY 1, 2023
Across the U.S., anti-LGBTQ legislation — and especially anti-trans legislation — is limiting queer youth’s access to everything from bathrooms to gender-affirming surgery. A new national survey from the Trevor Project paints a stark picture of the mental-health toll of these forces: LGBTQ youth consider and attempt suicide at alarmingly high rates, and nearly one-third say their mental health was poor “most of the time or always” due to anti-LGBTQ policies and
Fierce Healthcare
MAY 1, 2023
Chatbots outperformed doctors in answering patient questions with accuracy and empathy: JAMA study aburky Mon, 05/01/2023 - 13:58
STAT
MAY 1, 2023
On the first day back to school in April, after time off to celebrate the Persian New Year, students in Iran were greeted with another apparent chemical attack. This was just the most recent in a monthslong series of reports of students, in particular girls, apparently being poisoned. These chemical attacks , as they have been called, began in November 2022 and have escalated in recent months.
The Checkup by Singlecare
MAY 1, 2023
If you’ve been feeling more anxious than usual, it can be hard to tell if those feelings are a reasonable response to something stressful or worrying in your life or a sign that you have generalized anxiety disorder (GAD). Many people dismiss feelings of anxiety as temporary, or something they just need to “get over,” when in reality, they are struggling with a common—and, typically, treatable—mental health condition.
STAT
MAY 1, 2023
An investigation by a special committee of Stanford’s board of trustees into alleged scientific misconduct by Marc Tessier-Lavigne , the university’s president and a prominent neuroscientist, has involved “hundreds of hours of meetings and witness interviews” and will be “substantially complete” by mid-July, the panel said Sunday.
ISPE
MAY 1, 2023
The Re-Invention of CSV Templates and Pros & Cons Trudy Patterson Mon, 05/01/2023 - 14:47 iSpeak Blog iSpeak The Re-Invention of CSV Templates and Pros & Cons Dave Langerveld 1 May 2023 During 20 years of working in the Computer System Validation (CSV) arena, I was confronted with many different ways organizations try to define and control their CSV approach.
STAT
MAY 1, 2023
Japanese drugmaker Astellas said late Sunday it would acquire eye drug developer Iveric Bio for $5.9 billion, betting heavily on a prospective treatment for a form of vision loss that affects around 1 million people in the U.S. Iveric had been competing with another biotech, Apellis Pharmaceuticals, to develop the first therapy for geographic atrophy, a disease of aging in which parts of the retina waste away, forming irreversible blind spots.
Drug Store News
MAY 1, 2023
Revlon is looking to emerge from bankruptcy by forming a new board of directors with senior executives of such brands as Sephora, Bloomin’ and Walgreens Boots Alliance
STAT
MAY 1, 2023
Alexander Huth settled into an MRI machine in the Austin, Texas, neuroscience research building where he worked, a cozy blanket draped over him to stave off the chill from the machine’s magnet, and soundproof earbuds to drown out its drone. The sound in the earbuds, though, came through loud and clear. “From the New York Times and WBUR Boston, this is ‘Modern Love,’” the podcast began.
Drug Store News
MAY 1, 2023
DSN spoke to Stacey Ramstedt, vice president of marketing at Batiste, about its new campaign that focuses on helping Gen Z focus on their mental health and well-being.
STAT
MAY 1, 2023
WASHINGTON — Two hospitals that refused to provide an emergency abortion to a pregnant woman who was experiencing premature labor put her life in jeopardy and violated federal law, a first-of-its-kind investigation by the federal government has found. The findings, revealed in documents obtained by The Associated Press, are a warning to hospitals around the country as they struggle to reconcile dozens of new state laws that ban or severely restrict abortion with a federa
PharmExec
MAY 1, 2023
Biogen Inc. announced the approval, a groundbreaking treatment for adults with ALS, offering hope to patients suffering from SOD1-ALS, a rare and fatal genetic form of the disease.
STAT
MAY 1, 2023
SAN DIEGO — Travere Therapeutics, a biotech focused on treating rare diseases, on Monday announced that a Phase 3 trial of an experimental treatment for focal segmental glomerulosclerosis, a rare and deadly kidney disease, failed to improve kidney function. In the 371-person study, half of patients were randomly assigned to receive the drug, known as sparsentan, while the other half received irbesartan, a blood pressure treatment used as a control.
Fierce Healthcare
MAY 1, 2023
Doctors, influencers call on their peers to use social media to 'pre-bunk' dangerous misinformation aburky Mon, 05/01/2023 - 18:49
STAT
MAY 1, 2023
Despite significant public funding, most of the 15 largest public research universities in Canada failed to enact policies that would ensure medicines that emerged from their laboratories would be equally accessible around the world, according to a new analysis. Half of biomedical licensing agreements established at the universities during a recent two-year period did not insist on retaining exclusive control over underlying technologies.
Pharmacy Times
MAY 1, 2023
The final approval was based on efficacy and safety data from the phase 3 REST-ON study.
STAT
MAY 1, 2023
Babies born to opioid users had shorter hospital stays and needed less medication when their care emphasized parent involvement, skin-to-skin contact and a quiet environment, researchers reported Sunday. Newborns were ready to go home about a week earlier compared to those getting standard care. Fewer received opioid medications to reduce withdrawal symptoms such as tremors and hard-to-soothe crying, about 20% compared to 52% of the standard-care babies.
Drug Store News
MAY 1, 2023
CHPA said it takes responsibility for educating consumers about the safe and proper use of products and following the recommended usage on the label.
STAT
MAY 1, 2023
OAKLAND, Calif. — Primary care startup Carbon Health blasted health insurer Elevance on Monday for paying it less than competitors and for also refusing to process out-of-network claims — a rare public escalation of the behind-the-scenes disputes between providers and payers. San Francisco-based Carbon said that Elevance — formerly known as Anthem, which operates the Anthem Blue Cross plan in California — had refused to increase its payment rate in the state beyond 20
Expert insights. Personalized for you.
311 
Let's personalize your content